DCTH (Delcath Systems) Days Payable : 40.73 (As of Dec. 2024)

View and export this data going back to 2000. Start your Free Trial

What is Delcath Systems Days Payable?

Delcath Systems's average Accounts Payable for the three months ended in Dec. 2024 was $0.95 Mil. Delcath Systems's Cost of Goods Sold for the three months ended in Dec. 2024 was $2.13 Mil. Hence, Delcath Systems's Days Payable for the three months ended in Dec. 2024 was 40.73.

The historical rank and industry rank for Delcath Systems's Days Payable or its related term are showing as below:

DCTH' s Days Payable Range Over the Past 10 Years
Min: 58.19 Med: 788.71 Max: 3108.85
Current: 90.55

During the past 13 years, Delcath Systems's highest Days Payable was 3108.85. The lowest was 58.19. And the median was 788.71.

DCTH's Days Payable is ranked better than
60.28% of 793 companies
in the Medical Devices & Instruments industry
Industry Median: 69.21 vs DCTH: 90.55

Delcath Systems's Days Payable declined from Dec. 2023 (470.92) to Dec. 2024 (40.73). It may suggest that Delcath Systems accelerated paying its suppliers.

Delcath Systems Days Payable Historical Data

The historical data trend for Delcath Systems's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Delcath Systems Days Payable Chart

Delcath Systems Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Days Payable

Get a 7-Day Free Trial

1,798.48

656.02

706.59

870.83

58.19

Delcath Systems Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Days Payable	Get a 7-Day Free Trial															470.92	126.26	143.15	117.29	40.73

Competitive Comparison of Delcath Systems's Days Payable

For the Medical Devices subindustry, Delcath Systems's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Delcath Systems's Days Payable Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Delcath Systems's Days Payable distribution charts can be found below:

* The bar in red indicates where Delcath Systems's Days Payable falls into.

Delcath Systems Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Delcath Systems's Days Payable for the fiscal year that ended in Dec. 2024 is calculated as

	Days Payable (A: Dec. 2024 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2023 )	+	Accounts Payable (A: Dec. 2024 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2024 )	*	Days in Period
=	( (1.012	+	0.961)	/	2 )	/	6.188	*	365
=	0.9865					/	6.188	*	365
=	58.19

Delcath Systems's Days Payable for the quarter that ended in Dec. 2024 is calculated as:

	Days Payable (Q: Dec. 2024 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Sep. 2024 )	+	Accounts Payable (Q: Dec. 2024 ))	/	count )	/	Cost of Goods Sold (Q: Dec. 2024 )	*	Days in Period
=	( (0.937	+	0.961)	/	2 )	/	2.126	*	365 / 4
=	0.949					/	2.126	*	365 / 4
=	40.73

Delcath Systems Days Payable Related Terms

Thank you for viewing the detailed overview of Delcath Systems's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Delcath Systems Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Delcath Systems Inc (NAS:DCTH) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

DV3R:Germany DV3R:Germany

Address

566 Queensbury Avenue, Queensbury, NY, USA, 12804

Website

https://www.delcath.com

Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.

Executives

Gil Aharon	director	15 WELLESLEY STREET WEST, SUITE 326, TORONTO A6 M4Y 0G7
Salamon Steven A J	director	25 ADMIRAL ROAD, TORONTO A6 M5R 2L4
Vojo Vukovic	officer: See Remarks	C/O SYNTA PHARMACEUTICALS CORP., 45 HARTWELL AVENUE, LEXINGTON MA 02421
Gerard J Michel	director, officer: Chief Executive Officer	420 CHIPETA WAY, SALT LAKE CITY UT 84108
Sandra Pennell	officer: See Remarks	C/O VERICEL CORPORATION, 64 SIDNEY STREET, CAMBRIDGE MA 02139
David L. Hoffman	officer: See Remarks	C/O DELCATH SYSTEMS, INC., 1633 BROADWAY, SUITE 22C, NEW YORK NY 10019
John Purpura	officer: EVP, Regulatory Affairs	600 FIFTH AVENUE, 23RD FLOOR, NEW YORK NY 10020
John Richard Sylvester	director	C/O DELCATH SYSTEMS, INC., 1633 BROADWAY, SUITE 22C, NEW YORK NY 10019
Rosalind Advisors, Inc.	director, other: See Remarks	15 WELLESLEY STREET WEST, SUITE 326, TORONTO A6 M4Y 0G7
Kevin Muir	officer: See Remarks	C/O DELCATH SYSTEMS, INC., 1633 BROADWAY, SUITE 22C, NEW YORK NY 10019
Anthony Dias	officer: Vice President of Finance	C/O SEACHANGE INTERNATIONAL, 50 NAGOG PARK, ACTON MA 01720
Johnny John	officer: See Remarks	C/O DELCATH SYSTEMS, INC., 1633 BROADWAY, SUITE 22C, NEW YORK NY 10019
Elizabeth Czerepak	director	201 ROUTE 17 NORTH, RUTHERFORD NJ 07070
Christine Padula	officer: See Remarks	C/O DELCATH SYSTEMS, INC., 1633 BROADWAY, SUITE 22C, NEW YORK NY 10019
Simon Pedder	director	1001 MAIN STREET, SUITE 600, BUFFALO NY 14203